Analyst Ratings February 13, 2026

UBS Shifts Rivian Rating to Neutral, Flags Execution and Cash-Flow Hurdles

Analyst raises price target modestly as delivery guidance beats expectations but production and cash-burn risks persist

By Priya Menon RIVN
UBS Shifts Rivian Rating to Neutral, Flags Execution and Cash-Flow Hurdles
RIVN

UBS updated its view of Rivian Automotive, moving the stock from Sell to Neutral and nudging its price target upward, while highlighting the company's stronger-than-expected 2026 delivery guidance and ongoing concerns about production execution and cash flow. Other broker notes and leadership changes add context ahead of Rivian's upcoming fourth-quarter results.

Key Points

  • UBS moved Rivian's rating from Sell to Neutral and raised its price target to $16.00 from $15.00, citing a more balanced near-term risk/reward and partial valuation basis for the prior Sell rating.
  • Rivian's 2026 delivery guidance of 62,000-67,000 vehicles exceeded UBS expectations; the company reported 28.21% revenue growth over the last twelve months with forecasts implying roughly 8% growth for fiscal 2025.
  • Other broker activity and corporate moves include Benchmark's Q4 projections, Barclays keeping an Equalweight rating, Cantor Fitzgerald's Neutral stance noting the Autonomy+ offering, and the appointment of Azam Akhtar as CFO effective March 1.

UBS on Friday revised its stance on Rivian Automotive Inc (NASDAQ:RIVN), changing the stock rating from Sell to Neutral and raising its price target to $16.00 from $15.00. The analyst responsible for the move, Joseph Spak, framed the change as a response to a more balanced near-term risk/reward profile at current market levels, and noted that the prior Sell recommendation had been driven in part by valuation considerations.

The firm reiterated enthusiasm for Rivian's product portfolio, pipeline and brand strength, even as the stock's recent trading record has been mixed. Over the past year the shares have gained 5.26%, while year-to-date performance shows a 28.97% decline.

UBS pointed to Rivian's 2026 delivery guidance of 62,000 to 67,000 vehicles as a key data point. That outlook exceeded the firm's prior expectations and, according to UBS, creates potential for more robust performance in 2027 and beyond if Rivian can convert that guidance into realized production and sales. Rivian's reported revenue growth stands at 28.21% for the last twelve months, and consensus forecasts flagged in the note indicate an additional roughly 8% revenue increase for fiscal 2025.

Despite the more constructive near-term risk/reward assessment, UBS emphasized substantial execution and liquidity risks. The bank estimated that Rivian would need to deliver approximately 45,000 vehicles in the second half of 2026 overall, and around 22,000 units of the R2 model specifically, to meet its targets. UBS described that volume profile as requiring "near flawless production execution." The firm also called out ongoing cash burn and said the company is not expected to reach positive EBITDA for several years, adding skepticism about the likelihood of near-term positive earnings revisions.

Market valuation context in the UBS note included InvestingPro data showing Rivian trading near its Fair Value, with analyst price targets ranging from $10 to $25.

Additional broker commentary and corporate developments were noted ahead of Rivian's fourth-quarter earnings announcement. Benchmark projects fourth-quarter revenue of $1.27 billion, slightly above consensus of $1.26 billion, and expects an adjusted loss per share of $(0.61), compared with consensus at $(0.71). Barclays maintained an Equalweight rating, citing a shift in sentiment toward more negative fundamentals ahead of the earnings release. Cantor Fitzgerald reiterated a Neutral rating and highlighted Rivian's launch of an Autonomy+ subscription service priced substantially lower than Tesla's comparable offering.

Leadership changes were also reported: Rivian has appointed former General Motors executive Azam Akhtar as its new Chief Financial Officer, effective March 1.

Separately within the set of recent analyst actions, the coverage record also reflects a UBS move in which the firm took Rivian from Neutral to Sell while raising a price target to $15.00 from $13.00, a development the note described as reflecting concerns about elevated expectations. Those apparently differing analyst actions sit alongside the other broker views and company guidance as market participants weigh delivery execution, margin trajectories and cash-flow dynamics.


Contextual note - The developments outlined above come as Rivian prepares to report fourth-quarter results and as analysts balance upside from stronger-than-expected guidance with near-term operational and liquidity risks.

Risks

  • Production execution risk - UBS states Rivian needs about 45,000 deliveries in H2 2026 and roughly 22,000 R2 deliveries, which it says would require near flawless production execution.
  • Liquidity and profitability timeline - UBS flagged ongoing cash burn and expects positive EBITDA to remain several years away, indicating continued funding and margin pressure for the company.
  • Earnings revision skepticism and shifting sentiment - Brokers such as Barclays signaled more negative fundamentals ahead of earnings, and UBS expressed doubt about near-term positive earnings revisions.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026